Clinical significance and pathogenic function of connective tissue growth factor (CTGF/CCN2) in osteolytic mandibular squamous cell carcinoma

Anticancer Research

Volumn 28, Issue 4 C, 2008, Pages 2343-2348

  Shimo, Tsuyoshi ^a,c   Kubota, Satoshi ^a   Goda, Takeshi ^a   Yoshihama, Yasuto ^a   Kurio, Naito ^a   Nishida, Takashi ^a   Ng, Poh Sing ^b   Endo, Koki ^b   Takigawa, Masaharu ^a   Sasaki, Akira ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Nosan Corporation   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

CCN2; Mandibular bone destruction; Osteoclast

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CONNECTIVE TISSUE GROWTH FACTOR; PARAFFIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DESTRUCTION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MANDIBLE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PATHOGENESIS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; ANIMALS; BONE MARROW CELLS; CARCINOMA, SQUAMOUS CELL; CHO CELLS; CRICETINAE; CRICETULUS; FEMALE; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MANDIBULAR NEOPLASMS; MICE; MICE, INBRED C57BL; MIDDLE AGED; MOUTH NEOPLASMS; OSTEOCLASTS; RECOMBINANT PROTEINS;

EID: 48849083450     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Söderholm AL, Lindqvist C, Hietanen J and Lukinmaa PL: Bone scanning for evaluating mandibular bone extension of oral squamous cell carcinoma. J Oral Maxillofac Surg 48: 252-257, 1990.
2. Carter RL, Foster CS, Dinsdale EA and Pittam MR: Perineural spread by squamous carcinomas of the head and neck: a morphological study using antiaxonal and antimyelin monoclonal antibodies. J Clin Pathol 36: 269-275, 1983.
3. Rao LP, Das SR, Mathews A, Naik BR, Chacko E and Pandey M: Mandibular invasion in oral squamous cell carcinoma: investigation by clinical examination and orthopantomogram. Int J Oral Maxillofac Surg 33: 454-457, 2004.
4. Tsue TT, McCulloch TM, Girod DA, Couper DJ, Weymuller EA and Glenn MG: Predictors of carcinomatous invasion of the mandible. Head Neck 16: 116-126, 1994.
5. Langdon JD, Harvey PW, Rapidis AD, Patel MF, Johnson NW and Hopps R: Oral cancer: the behaviour and response to treatment of 194 cases. J Maxillofac Surg 5: 221-237, 1977.
6. Snow JB, Gelber RD, Kramer S, David LW, Marcial VA and Lowry LD: Randomised preoperative and postoperative radiation therapy for patients with carcinoma of the head and neck: preliminary report. Laryngoscope 96: 930-940, 1980.
7. Perbal B and Takigawa M: CCN Proteins: A New Family of Cell Growth and Differentiation Regulators. London, Imperial College Press, pp. 1-311, 2005
8. Nakanishi T, Nishida T, Shimo T Kobayashi K, Kubo T, Tamatani T, Tezuka K and Takigawa M: Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology 141: 264-273, 2000.
9. Shimo T, Koyama E, Sugito H, Wu C, Shimo S and Pacifici M: Retinoid signaling regulates CTGF expression in hypertrophic chondrocytes with differential involvement of MAP kinases. J Bone Miner Res 20: 867-877, 2005.
10. Nishida T, Kubota S, Kojima S, Kuboki T, Nakao K, Kushibiki T, Tabata Y and Takigawa M: Regeneration of defects in articular cartilage in rat knee joints by CCN2 (connective tissue growth factor). J Bone Miner Res 19: 1308-1319, 2004.
11. Shimo T, Nakanishi T, Kimura Y, Nishida T, Ishizeki K, Matsumura T and Takigawa M: Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells. J Biochem 124: 130-140, 1998.
12. Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama M, Kuboki T, Tamatani T, Tezuka K, Takemura M, Matsumura T and Takigawa M: Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 126: 137-145, 1999.
13. Shimo T, Nakanishi T, Nishida T, Asano M, Sasaki A, Kanyama M, Kuboki T, Matsumura T and Takigawa M: Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis. Oncology 61: 315-322, 2001.
14. Shimo T, Kubota S, Yoshioka N, Ibaragi S, Isowa S, Eguchi T, Sasaki A and Takigawa M: Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer. J Bone Miner Res 21: 1045-1059, 2006.
15. Brown JS, Griffith JF, Phelps PD and Browne RM: A comparison of different imaging modalities and direct inspection after periosteal stripping in predicting the invasion of the mandible by oral squamous cell carcinoma. Br J Oral Maxillofac Surg 32: 347-359, 1994.
16. Boyde A, Maconnachie E, Reid SA, Delling G and Mundy, GR: Scanning electron microscopy in bone pathology: review of methods. Potential and applications. Scanning Electron Microsc 4: 1537-1554, 1986.
17. Yoneda T and Hiraga T: Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem Biophys Res Commun 328: 679-687, 2005.
18. Pfeilschifter J and Mundy GR: Modulation of transforming growth factor β activity in bone cultures by osteotrophic hormones. Proc Natl Acad Sci USA 84: 2024-2028, 1987.
19. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA and Massague J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549, 2003.
20. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ and Suda T: Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Bone 25: 517-523, 1999.
21. Hanahan D and Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996.
22. Winding B, Misander H, Sveigaard C, Therkildsen B, Jakobsen M, Overgaard T, Oursler MJ and Foged NT: Human breast cancer cells induced angiogenesis, recruitment, and activation of osteoclasts in osteolytic metastasis. J Cancer Res Clin Oncol 126: 631-640, 2000.
23. Pluijm G, Lowik C and Papapoulos S: Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem. Cancer Treat Rev 26: 11-27, 2000.
24. Sasaki A, Alcalde RE, Nishiyama A, Lim DD, Mese H, Akedo H and Matsumura T: Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption. Cancer Res 58: 462-467, 1998.
25. Peyruchaud O, Serre CM, NicAmhlaoibh R, Fournier P and Clezardin P: Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity. J Biol Chem 278: 45826-45832, 2003.